Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A.
Saved in:
| Title: | Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A. |
|---|---|
| Authors: | Migliarese, Christian1 (AUTHOR), Sadeh, Yinon1 (AUTHOR), Torrini, Consuelo2 (AUTHOR), Turna Demir, Fatma1,3 (AUTHOR), Nayyar, Naema2 (AUTHOR), Yamazawa, Erika2 (AUTHOR), Ishikawa, Yuu1 (AUTHOR), Ijad, Nazanin2 (AUTHOR), Summers, Elizabeth J.2 (AUTHOR), Elliott, Adam4 (AUTHOR), Rahbaek, Lisa4 (AUTHOR), Saechao, Barbara4 (AUTHOR), Hallin, Jill4 (AUTHOR), Brastianos, Priscilla K.2 (AUTHOR) pbrastianos@mgh.harvard.edu, Wakimoto, Hiroaki1 (AUTHOR) hwakimoto@mgh.harvard.edu |
| Source: | Acta Neuropathologica Communications. 5/2/2025, Vol. 13 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
